Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Trade Name: Apo-Oxybutynin. Active Ingredient(s): Oxybutynin hydrochloride 1 mg/mL. Dosage Form: Syrup. NZ Sponsor: Apotex (NZ) Limited. Manufacturer(s): Novex Pharma Inc, Richmond Hill, Ontario, Canada. Dated this 19th day of July 1999. G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).